Australian Technical Advisory Group on Immunisation: Difference between revisions
Content deleted Content added
re-worded a sentence in lead - detail; AZD1222 wikilink; removed capital from Main; expanded cites |
→Roles: AUS sp |
||
| Line 24: | Line 24: | ||
* The main role of ATAGI is to provide advice on the administration of vaccinations related to the [[National Immunisation Program Schedule|National Immunisation Program]] (NIP) to the Minister of Health |
* The main role of ATAGI is to provide advice on the administration of vaccinations related to the [[National Immunisation Program Schedule|National Immunisation Program]] (NIP) to the Minister of Health |
||
* Advisory on the ongoing immunisation research or the most needed areas |
* Advisory on the ongoing immunisation research or the most needed areas |
||
* furnish industry supports with pre-accommodation guidance for likely entries to the Pharmaceutical Benefits Advisory Committee (PBAC) on |
* furnish industry supports with pre-accommodation guidance for likely entries to the Pharmaceutical Benefits Advisory Committee (PBAC) on immunisation viability and use in Australia. ATAGI guidance should be looked for before support making an accommodation to the PBAC |
||
* Discussion with pertinent associations to create the Australian |
* Discussion with pertinent associations to create the Australian Immunisation Handbook |
||
* Discussion with significant associations in carrying out vaccination arrangements, strategies and immunization security |
* Discussion with significant associations in carrying out vaccination arrangements, strategies and immunization security |
||
Revision as of 01:11, 13 April 2021
| Agency overview | |
|---|---|
| Formed | February 1, 1998[1] |
| Jurisdiction | Australian Government |
| Motto | Advising the Minister for Health on the medical administration of vaccines |
| Employees | 17 members |
| Agency executives |
|
| Parent department | Department of Health |
| Website | health |
The Australian Technical Advisory Group on Immunisation (ATAGI) is a technical advisory group of the Australian Government. As part of the Department of Health, ATAGI provides advice to the Minister of Health on the immunisation program of Australia and related matters, including the strength of evidence pertaining to existing, new, and emerging vaccines.[1][2][3]
Roles
ATAGI's role[2]
- The main role of ATAGI is to provide advice on the administration of vaccinations related to the National Immunisation Program (NIP) to the Minister of Health
- Advisory on the ongoing immunisation research or the most needed areas
- furnish industry supports with pre-accommodation guidance for likely entries to the Pharmaceutical Benefits Advisory Committee (PBAC) on immunisation viability and use in Australia. ATAGI guidance should be looked for before support making an accommodation to the PBAC
- Discussion with pertinent associations to create the Australian Immunisation Handbook
- Discussion with significant associations in carrying out vaccination arrangements, strategies and immunization security
Members
| S no. | Position | Name | Start Date | End Date |
|---|---|---|---|---|
| 1 | Chair | A/Prof Christopher Blyth | 1 July 2020 | 30 June 2021 |
| 2 | Chair | Prof. Allen Cheng | 1 July 2020 | 30 June 2021 |
| 3 | Member | Ms. Karen Ballamy | 1 July 2019 | 30 June 2023 |
| 4 | Member | Prof. Tom Snelling | 1 July 2019 | 30 June 2023 |
| 5 | Member | A/Prof Nigel Crawford | 1 July 2019 | 30 June 2023 |
| 6 | Member | James Wood | 14 September 2020 | NA |
| 7 | Member | Dr. Nicholas Silberstein | 1 July 2019 | 30 June 2021 |
| 8 | Member | Prof Katie Flanagan | 1 July 2019 | 30 June 2023 |
| 9 | Member | Assoc Prof Michelle Giles | 1 July 2019 | 30 June 2021 |
| 10 | Member | Ms. Diane Walsh | 14 September 2020 | 30 June 2023 |
| 11 | Member | Ms. Madeline Hall | 1 July 2019 | 30 June 2021 |
| 12 | Member | Ms. Debra Petrys | 1 July 2019 | 30 June 2021 |
| 13 | Member | Kristy Cooper | 25 January 2021 | 30 June 2025 |
| 14 | Member | Prof. Cheryl Jones | 1 July 2019 | 30 June 2023 |
| 15 | Member | Dr. Katherine Gibney | 1 July 2019 | 30 June 2023 |
| 16 | Member | Prof. Bette Liu | 1 July 2019 | 30 June 2023 |
| 17 | Member | Prof. Tony Korman | 1 July 2019 | 30 June 2023 |
Meeting
Australian Technical Advisory Group on Immunisation (ATAGI) often schedule 6 meetings, unless more are needed, according to organised agendas and bulletins for the year.
On 8 April 2021, ATAGI met with the Therapeutic Goods Administration (TGA) regarding the recent concerns of blood clots following administration of the Oxford–AstraZeneca COVID-19 vaccine. ATAGI advised the government to use the AstraZeneca vaccine only for people over the age of 50.[4][5]
See also
Notes
References
- ^ a b Australian Government (9 December 2020). "Australian Technical Advisory Group on Immunisation". Department of Health Directory. Retrieved 11 April 2021.
{{cite web}}: CS1 maint: url-status (link) - ^ a b Australian Government; Department of Health (18 March 2021). "Australian Technical Advisory Group on Immunisation (ATAGI)". Department of Health. Retrieved 11 April 2021.
{{cite web}}: CS1 maint: url-status (link) - ^ Victoria State Government Department of Health; SafeVic; Murdoch Children's Research Institute (October 2020). "Australian Technical Advisory Group on Immunisation (ATAGI)". Melbourne Vaccine Education Centre. Retrieved 11 April 2021.
{{cite web}}: CS1 maint: url-status (link) - ^ Australian Government, Department of Health (8 April 2021). "ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns". Australian Technical Advisory Group on Immunisation. Retrieved 9 April 2021.
- ^ "AstraZeneca vaccine: How new advice means total REPLAN of vaccine rollout". 7news. 8 April 2021. Retrieved 11 April 2021.